With the regulatory path forward for hemp-derived CBD in foods and supplements no clearer a year after the FDA’s May 2019 public meeting, trade association The Council for Responsible Nutrition (CRN) has filed a citizen’s petition urging the FDA to regulate...
A US Food and Drug Administration study reveals that a number of the products it tested labeled as ‘bitter orange’ did not meet label claim for synephrine content and more than 10% contained undeclared synthetic ingredients.
The prevalence of virus-treatment claims in the marketplace has made for both heightened enforcement from federal regulators and calls for even more action from an advocacy group regarding products sold on Amazon.
The Natural Products Association (NPA) is calling for the US Food and Drug Administration to use import alerts to stop nutritional supplements that fail to comply with New Dietary Ingredient (NDI) regulations.
A judge has approved a permanent injunction order against the principals of a dietary supplement company who allegedly repeatedly ignored FDA warnings and inspection findings on illegal disease claims and other violations.
The National Advertising Division has ruled that GSK must stop calling some of its Benefiber prebiotic supplements ‘100% natural.’ It’s a ruling that could be viewed as troublesome for other prebiotic ingredients.
A new stakeholder group has come together to push for quality and transparency in the dietary supplement industry. Called the Dietary Supplement Quality Collaborative (DSQC), the group published a policy paper recently as part of its public debut.
Both local Chinese and foreign infant nutrition brands in China are urged to “push hard on safety cues and messages” in light of the recent infant nutrition scandal happening in the country, according to an industry expert.
The Federal Trade Commission has sent out another round of warning letters to 50 more marketers nationwide, most of which are labeled as dietary supplements or Chinese herbs.
The boom in hemp cultivation after the passage of the 2018 Farm Bill has created a supply bulge that the industry is still working through, observers say.
New claims creeping into the hemp/CBD space are indicative of the some of the unsolved regulatory issues that continue to distort the market. These include claims of ‘zero THC’ and ‘no CBD isolate.’
The Federal Trade Commission just announced it is issuing refund checks totaling over $8.5 million to consumers defrauded by misleading claims on weight loss products an erectile dysfunction product in a case dating back to 2004.
As cannabis legalization spreads across the country, professional sports leagues are updating their policies, while some players update their portfolios.
The Food and Drug Administration (FDA) may have suspended all routine plant inspections, but dietary supplement producers are still expected to remain in compliance. In the meantime, the Federal Trade Commission has sent another 37 warning letters over...
Network marketing giant Herbalife has announced an agreement in principle with US authorities over a bribery scandal in China. The reported pact, which includes a $123 million fine, was part of the company’s first quarter earnings report, which came...
The Council for Responsible Nutrition has announced that a program it had supported at the National Advertising Division will end as the major funding source has been exhausted. But both CRN and NAD said the information contained in the more than 350...
The state of Texas has proposed rules for consumable hemp products that specify processing, testing, labeling and registration requirements. While the rules are characterized as reasonable and well thought out, they represent another patch in a state-by-state...
Some producers of essential oils have thrown their hats into the coronavirus claims ring, according to recent warning letters from the US Food and Drug Administration and the Federal Trade Commission.
Given the current torrid pace of sales for some categories, the dietary supplement industry could emerge from the present crisis is a significantly strengthened position. Even categories that are in the doldrums stand to benefit.
Marketers of natural products need to be on their best behavior during this pandemic crisis as regulatory authorities comb through every aspect of a company’s marketing to look for disease claims, an attorney says.
Mile High Labs has submitted a European novel foods dossier for its CBD isolate. According to Christian Hendriksen, vice president of international expansion, compliance with novel food regulations will help move CBD into the FMCG mainstream.
Health Canada has reiterated its stance that changes to product labels due to reclassification of species within the old Lactobacillus genus should occur within three years of changes to its monograph.
The sad news came this week of the death of a young girl who started a movement, one which has exposed again the built-in strains of how the dietary supplement market is regulated in the United States.
Neptune Health and Wellness has received approval to transition one of its facilities for the production of hand sanitizer, the company announced today.
The US Food and Drug Administration has issued an additional six warning letters in recent days on coronavirus claims. The letters coincide with an industry coalition raising a red flag on the growing flood of such claims on dietary supplement-type products.
A coalition of dietary supplement industry trade associations have come out in support of FDA actions against fraudulent coronavirus treatment claims and have urged retailers to not stock products with such claims on their labels.
An omega-3 origin verification tech company is working to boost awareness in an aim to build a new and improved level of trust and transparency across the industry.
The dietary supplement industry has an opportunity to communicate with a new range of consumers in light of the current crisis. Highlighting the excellent safety of the products and quality initiatives underway can help keep the embarrassment of rampant...
The Botanical Adulteration Prevention Program has issued a lab guidance document on turmeric. The publication is timely as interest in the botanical, which was already high, has spiked during the current coronavirus crisis.
A ruling on an Amarin patent and a new paper looking through data of a clinical trial on the company’s EPA-based drug have potential implications for the omega-3s dietary supplements sector.
The US Food and Drug Administration has issued another warning letter on COVID-19 claims. This one was issued to a Nevada company marketing CBD products.
A new federal government update on who may be considered essential workers now specifically includes employees of dietary supplement manufacturing and sales operations. Trade groups said it’s now up to industry to make sure that is reflected in local...
The increasing popularity of cannabidiol (CBD) only underscores the need for accurate and informative labeling of hemp and hemp-derived CBD products, according to researchers.
The $2 trillion stimulus packaged passed unanimously by the US Senate this morning will have important implications for the dietary supplement industry that may help companies survive the worst of the coronavirus crisis impacts.
Dietary supplement companies may store adverse event reports and submit them after the present crisis is past, the US Food and Drug Administration said recently.
Synthetic astaxanthin product developer Cardax has released a white paper and reportedly filed a patent application on the ingredient’s antiviral properties and in publicizing the fact has treaded on the disease claim line according to legal experts.
With FDA receding into the inspection background, now is the time for the dietary supplement industry to step up and show if there are any real teeth in the notion of self regulation.
Dietary supplement manufacturers and the natural channel stores that sell the products play an important role in supporting consumers health during this challenging time and should be counted as ‘essential’ businesses, stakeholders say.
While the COVID-19 crisis dominates headlines, a raft of state and local laws that could negatively affect the dietary supplement industry are afoot and deserve attention, according the Council for Responsible Nutrition.
In a teleconference held last night the US Food and Drug Administration announced that it is scaling back GMP inspections and is waiving certain FSMA requirements in the face of the COVID-19 crisis.
As the news about COVID-19 becomes ever more sobering, the question becomes what dietary supplements might do to help. I think there is opportunity here, but talking about it requires walking a tightrope over a gulf of regulatory peril.
The German Food and Agriculture Ministry (BMEL) has refuted an EU hemp group missive that the Ministry had changed its position regarding the novel food requirement for some cannabidiol (CBD) extracts in the EU.
The FTC is revisiting its Endorsement Guides and seeking public comment on what changes might be needed as it initiates an enforcement action on health claims made by influencers.
Contract manufacturer Icelandirect has announced it has achieved organic certification, the company announced recently, which is part of a trend of widening organic options with the dietary supplement industry.
The US Food and Drug Administration has sent warning letters to seven companies that have been alleged to have been making COVID-19 disease treatment claims. Among the recipients of the warning letters is a prominent televangelist.
